Literature DB >> 1322238

In vivo growth of C6 glioma cells transfected with connexin43 cDNA.

C C Naus1, K Elisevich, D Zhu, D J Belliveau, R F Del Maestro.   

Abstract

In order to examine the possible role of intercellular communication via gap junctions in the control of tumor growth, we have transfected C6 glioma cells with connexin43 cDNA. We obtained several clones with variable expression of connexin43. The growth rate of these clones in culture was inversely related to the degree of expression of the transfected cDNA. To examine the growth of these transfected cells in vivo, cells were grown in spinner culture flasks to form spheroids 250-300 microns in diameter. Spheroids of nontransfected C6 cells produced large gliomas. Immunohistochemical and in situ hybridization analyses revealed relatively high levels of connexin43 protein and mRNA in the host tissue, while little of this protein was detected in the glioma. In contrast, spheroids of connexin43-transfected cells grew more slowly and exhibited elevated levels of connexin43 protein and mRNA. These findings suggest that the expression of connexin43 may be associated with the control of brain tumor growth in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322238

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein.

Authors:  D Zhu; G M Kidder; S Caveney; C C Naus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.

Authors:  Maria Artesi; Jerome Kroonen; Markus Bredel; Minh Nguyen-Khac; Manuel Deprez; Laurent Schoysman; Christophe Poulet; Arnab Chakravarti; Hyunsoo Kim; Denise Scholtens; Tatjana Seute; Bernard Rogister; Vincent Bours; Pierre A Robe
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

3.  Connexin43 increases the sensitivity of prostate cancer cells to TNFalpha-induced apoptosis.

Authors:  Min Wang; Viviana M Berthoud; Eric C Beyer
Journal:  J Cell Sci       Date:  2007-01-02       Impact factor: 5.285

Review 4.  Glial connexins and gap junctions in CNS inflammation and disease.

Authors:  Tammy Kielian
Journal:  J Neurochem       Date:  2008-04-10       Impact factor: 5.372

Review 5.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 6.  Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics.

Authors:  Christina L Grek; Zhi Sheng; Christian C Naus; Wun Chey Sin; Robert G Gourdie; Gautam G Ghatnekar
Journal:  Curr Opin Pharmacol       Date:  2018-05-24       Impact factor: 5.547

7.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Authors:  Manuel Nieto-Sampedro; Beatriz Valle-Argos; Diego Gómez-Nicola; Alfonso Fernández-Mayoralas; Manuel Nieto-Díaz
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

8.  Aberrant expression, function and localization of connexins in human esophageal carcinoma cell lines with different degrees of tumorigenicity.

Authors:  Y Oyamada; M Oyamada; A Fusco; H Yamasaki
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

Authors:  S H Chen; H D Shine; J C Goodman; R G Grossman; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 10.  Targeting different domains of gap junction protein to control malignant glioma.

Authors:  Jun Wang; Ze-Yu Yang; Yu-Feng Guo; Jing-Ya Kuang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.